Sunny Christian

Sunny Christian has a diverse work experience in the pharmaceutical industry. Starting in 2012, Sunny worked as a Research Associate at Piramal Discovery Solutions - PDS, where they conducted analysis of New Chemical Entities (NCEs) and performed structural elucidation using various techniques. From 2013 to 2014, Sunny worked as an Analytical Development Lab Executive at Torrent Pharmaceuticals Ltd, focusing on developing analytical methods and analyzing APIs, raw materials, and formulations. From 2017 to 2020, Sunny worked as a Pharmaceutical Development & Regulatory Associate at Tara Innovations LLC, where they were involved in CMC development of liquid parenteral formulations and authored regulatory documents. From 2020 to 2021, Sunny worked as a Formulation Scientist at Penn Life-sciences, responsible for formulation development of injectable and ophthalmic pharmaceutical products. Most recently, Sunny held the role of R&D Formulation Scientist - II at Akorn, Inc from 2021 to 2022, where they conducted literature and patent reviews, performed risk assessments for formulation/process development, and prepared quality documents to support submission. Currently, Sunny is a Senior Manager at Aviceda Therapeutics since 2022.

Sunny Christian completed their Bachelor's degree in Pharmacy from the University in 2010. From 2010 to 2012, they pursued a Master of Science (M.S.) degree in Pharmaceutical Analysis from Gujarat Forensic Sciences University. In 2011, Sunny also obtained a Post Graduate Diploma in Patent Laws from the National Academy of Legal Studies & Research (NALSAR) University Hyderabad through distance learning. Finally, from 2015 to 2017, Sunny pursued a Master of Science (M.S.) degree in Pharmacy Administration and Pharmacy Policy and Regulatory Affairs from Long Island University.